9 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
RESOLving INflammation Through Diet for Health (RESOLVIN)Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorderRecruitingNot applicable2026-10-09NCT07331103
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal HemoglobinuriaHemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuriaActive, not recruitingPhase 32026-08-07NCT04747613
Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActinomycetales infectious disease, Bacterial Infections and Mycoses, COVID-19, Clostridium infectious disease, Coronaviridae Infections, Corynebacterium Infections, DNA Virus Infections, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, Varicella Zoster Virus Infection, bacterial infectious disease, diphtheria, follicular lymphoma, gram-positive bacterial infections, herpes zoster, immune system disorder, immunoproliferative disorder, lung disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, pneumonia, respiratory system disorder, respiratory tract infectious disorder, tetanus, viral infectious disease, viral pneumoniaActive, not recruitingNot stated2026-06-26NCT06070961
REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal HemoglobinuriaHemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, anemia, bone marrow disorder, hematologic disorder, hemolytic anemia, myelodysplastic syndromeRecruitingNot stated2026-06-25NCT07229235
GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in the Treatment of Metastatic HER-2 Positive Breast Cancer Patients in Real World SettingNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderRecruitingNot stated2026-05-13NCT07583485
CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 32026-05-06NCT02918084
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia PatientsHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22026-03-06NCT05306301
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderNot yet recruitingNot stated2025-03-13NCT06871501
Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic SyndromesCytopenia, Hemic and Lymphatic Diseases, blood platelet disease, bone marrow disorder, hematologic disorder, myelodysplastic syndrome, thrombocytopeniaActive, not recruitingPhase 22022-01-28NCT02912208